Research Paper Discussing the Use of CRISPR to Target GABA Receptors in Treatment for Depression
View Polygence scholar page
In Medha's research paper, she explored how the usage of CRISPR technologies could be used as a potential treatment for major depressive disorder. Major depressive disorder affects about 1 in 6 people throughout their lifetime and comes along with detrimental side effects. Her paper discusses the genetics of depression, CRISPR and gene therapies, the ethics of using CRISPR, and the challenges gene therapies present specifically in the brain.
Medha wrote a research paper, and she is currently in the process of submitting it to journals.Read her paper